| מסגרת זמן | מחיר חזוי | עָבָר | הִיסטוֹרִי | תוֹבָנָה |
|---|---|---|---|---|
| מָחָר | $35.23 ▼ -1.06% | אֶתמוֹל | $35.77 ▲ +0.45% | Tomorrow's Stoke Therapeutics Inc. Common Stock (STOK) setup is anchored to $35.61 and targets $35.23 (-1.06%). The near-term read is downside; watch $36.68 / $34.54 because daily realized volatility is about 5.47%. |
Tomorrow's Stoke Therapeutics Inc. Common Stock (STOK) setup is anchored to $35.61 and targets $35.23 (-1.06%). The near-term read is downside; watch $36.68 / $34.54 because daily realized volatility is about 5.47%. | ||||
| שָׁבוּעַ | $34.43 ▼ -3.30% | שבוע שעבר | $36.10 ▲ +1.39% | The 7-day Stoke Therapeutics Inc. Common Stock model moves from $36.10 to $34.43 (-3.30%). It gives downside momentum context for this stock, so breaks around $36.68 / $34.54 matter more than a single tick. |
The 7-day Stoke Therapeutics Inc. Common Stock model moves from $36.10 to $34.43 (-3.30%). It gives downside momentum context for this stock, so breaks around $36.68 / $34.54 matter more than a single tick. | ||||
| חוֹדֶשׁ | $33.11 ▼ -7.03% | חודש שעבר | $36.66 ▲ +2.95% | The 1-month Stoke Therapeutics Inc. Common Stock target is $33.11 (-7.03%), compared with the live reference near $35.61. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Stoke Therapeutics Inc. Common Stock target is $33.11 (-7.03%), compared with the live reference near $35.61. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| שָׁנָה | $31.12 ▼ -12.62% | אֶשׁתָקַד | $37.50 ▲ +5.30% | The 1-year Stoke Therapeutics Inc. Common Stock scenario points to $31.12 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Stoke Therapeutics Inc. Common Stock scenario points to $31.12 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 שנים | $26.45 ▼ -25.71% | לפני 5 שנים | $39.46 ▲ +10.80% | The 5-year Stoke Therapeutics Inc. Common Stock view is $26.45 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Stoke Therapeutics Inc. Common Stock view is $26.45 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| מַד | עֵרֶך | אוֹת |
|---|---|---|
| Price | $35.61 | Mid |
| Daily Change | -2.33% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 62% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $35.61 | Daily Change | -2.33% |
| Market Cap | $2.11B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.